TGA to cut fees for manufacturers of low wholesale turnover drugs
News | 31 July 2012
Breaking News on Global Pharmaceutical Technology & Manufacturing. Ingredients · Drug Delivery · Processing · Regulatory & Safety. Headlines. Ingredients · Drug Delivery · Processing · Regulatory & Safety · Video · Audio · Gallery · This month (July ...
Click on the link to read the full article at In-PharmaTechnologist.com
(This link will open in a new window)
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
